GAS5 and cancer: Thus in cancers with deficient GAS5 expression, the GAS5 HREM oligonucleotide may have therapeutic potential, not only by acting as an apoptotic inducer per se, but also by restoring the effectiveness of more conventional oncotherapies on therapy-resistant cancer cells.